Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-023989
Filing Date
2025-05-08
Accepted
2025-05-08 18:57:52
Documents
1
Period of Report
2025-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1746745065.html 4  
1 FORM 4 wk-form4_1746745065.xml 4 7630
  Complete submission text file 0001628280-25-023989.txt   9084
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
George Jeffrey P. (Reporting) CIK: 0001796789 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 25927856